Global Top 10 Medtechs Swap Places After Latest Quarterlies
Market pressures, changing COVID-related demand, restructuring and currency movements evident in the top medtechs’ latest financials
Executive Summary
Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished 2022 with strong quarters, and Roche dropped a few places.
You may also be interested in...
Medtronic Cuts Away More: Spins Off Patient Monitoring And Respiratory Business
Medtronic announced plans to spin off its patient monitoring and respiratory interventions businesses, which currently provide revenues of over $2bn a year. The company previously signaled plans to make significant changes to its business portfolio.
Podcast: German Hospital Reform Ushers In A Reimbursement ‘Revolution’
Germany is introducing a new system of paying for inpatient care, whereby funds will be allocated both to diagnosis related groups and to a provisional pot from which funds will be distributed according to the type of care delivered. In this podcast with Medtech Insight, Gabriel Flemming of Germany Trade & Invest explains what it all means for medtech.
Released: Germany’s Digital Strategy Will Transform Health And Care
An intense period of work overseen by Germany’s health ministry has culminated in the release of a new digital health care strategy. Germany now has a clear direction for how care will be transformed, says e-health chief Sebastian Zilch.